Status:
UNKNOWN
Effect Of Intermittent Fasting To Metabolic And Oxidative Stress Marker
Lead Sponsor:
Anni Rahmawati
Conditions:
Obesity
Eligibility:
MALE
30-59 years
Phase:
NA
Brief Summary
The world prevalence of obesity in adult population in 2016 was 650 million while in Indonesia, it has increased from 14,8 percent to 21,8 percent in 2018. Obesity is an established risk factors for m...
Detailed Description
Intermittent fasting is eating pattern in that cycles between periods of fasting and eating. 5:2 intermittent fasting (IF) is a form of time-restricted fasting which no calories are consumed for at le...
Eligibility Criteria
Inclusion
- Men aged 30-59 years
- Has a BMI ≥ 25 kg/m\^2
- Has a waist circumference of ≥ 90 cm
- Willingness to participate in the whole study by signing informed consent
Exclusion
- Doing regular fasting (2 days a week) for 12 weeks before the study begins.
- In a certain diet at the moment
- Participants who are taking drugs that can affect blood sugar, insulin, and drugs (steroids, beta blockers, adrenergics), vitamins or herbal supplements and other drugs that affect oxidative stress.
- Participants suffering from obesity with complications such as impaired liver function, impaired kidney function, heart disease and type 2 diabetes mellitus are known through anamnesis and physical examination as well as fasting blood sugar checks.
- Participants that has a fever with temperatures\> 37.5 ℃
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04319133
Start Date
June 1 2020
End Date
September 1 2020
Last Update
April 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PT DELAMITA BiILANO
Jakarta, Indonesia, 13260